Skip to main content
Year archive

Aptabio Therapeutics Inc. — 2021 filings

All 32 regulatory filings released by Aptabio Therapeutics Inc. (293780) in 2021, sourced directly from the official regulator.

32 Filings
2021 Period
2021 filings (32)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-16 Korean
기타경영사항(특허권취득)(자율공시)(신규한 피라졸 유도체)
Regulatory Filings
2021-11-29 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-11-16 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-15 Korean
기타경영사항(특허권취득)(자율공시)(3-페닐-4-프로필-1-(피리딘-2-일)-1H-피라졸-5-올 염산염의 신규 결정형 고체화합물)
Regulatory Filings
2021-10-14 Korean
기타경영사항(특허권취득)(자율공시)(조영제 유발 급성 신부전 치료제)
Regulatory Filings
2021-09-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-08-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-08-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-08-25 Korean
권리락(무상증자)
Share Issue/Capital Change
2021-08-23 Korean
기타경영사항(특허권취득)(자율공시)(3-페닐-4-프로필-1-(피리딘-2-일)-1H-피라졸-5-올 염산염의 신규 결정형 고체화합물)
Regulatory Filings
2021-08-19 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-13 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change
2021-08-09 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change
2021-08-09 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change
2021-08-09 Korean
기타경영사항(특허권취득)(자율공시)(간질환 치료제(Therapeutic Agent For Liver Disorder))
Regulatory Filings
2021-08-04 Korean
기타경영사항(특허권취득)(자율공시)(3-페닐-4-프로필-1-(피리딘-2-일)-1H-피라졸-5-올 염산염의 신규 결정형 고체화합물)
Regulatory Filings
2021-07-07 Korean
기타경영사항(특허권취득)(자율공시)(혈액암 치료제)
Regulatory Filings
2021-06-24 Korean
기타경영사항(특허권취득)(자율공시)(안질환 예방 또는 치료용 점안 조성물)
Regulatory Filings
2021-06-14 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-14 Korean
기타경영사항(특허권취득)(자율공시)(혈액암 치료제)
Regulatory Filings
2021-04-06 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-03-30 Korean
투자판단관련주요경영사항(COVID-19 치료제 APX-115의 US FDA 2상 임상시험 IND 승인)
Regulatory Filings
2021-03-24 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-22 Korean
사업보고서 (2020.12)
Annual Report FY 2020
2021-03-22 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2021-03-15 Korean
주주총회집중일개최사유신고
AGM Information
2021-03-15 Korean
기타경영사항(특허권취득)(자율공시)(간질환 치료제)
Regulatory Filings
2021-03-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-01-29 Korean
주주총회소집결의
AGM Information
2021-01-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-01-29 Korean